Yixintang Pharmaceutical Group Co., Ltd. (002727.SZ)
CNY 13.93
(-0.5%)
CNY 13.93
(-0.5%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 16.64 Billion CNY | 2.89% |
| 2022 | 16.17 Billion CNY | 12.85% |
| 2021 | 14.33 Billion CNY | 53.7% |
| 2020 | 9.32 Billion CNY | 17.15% |
| 2019 | 7.96 Billion CNY | 8.25% |
| 2018 | 7.35 Billion CNY | 2.93% |
| 2017 | 7.14 Billion CNY | 18.85% |
| 2016 | 6.01 Billion CNY | 43.64% |
| 2015 | 4.18 Billion CNY | 42.32% |
| 2014 | 2.94 Billion CNY | 41.9% |
| 2013 | 2.07 Billion CNY | 35.98% |
| 2012 | 1.52 Billion CNY | 16.51% |
| 2011 | 1.3 Billion CNY | 18.43% |
| 2010 | 1.1 Billion CNY | 61.17% |
| 2009 | 685.4 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 17.54 Billion CNY | 5.37% |
| 2024 Q3 | 17.13 Billion CNY | -2.1% |
| 2024 Q2 | 17.49 Billion CNY | -0.24% |
| 2023 Q3 | 16.32 Billion CNY | 2.87% |
| 2023 Q4 | 16.64 Billion CNY | 2.0% |
| 2023 Q1 | 16.41 Billion CNY | 1.47% |
| 2023 FY | 16.64 Billion CNY | 2.89% |
| 2023 Q2 | 15.86 Billion CNY | -3.35% |
| 2022 Q1 | 14.49 Billion CNY | 1.12% |
| 2022 FY | 16.17 Billion CNY | 12.85% |
| 2022 Q4 | 16.17 Billion CNY | 7.35% |
| 2022 Q3 | 15.07 Billion CNY | 4.84% |
| 2022 Q2 | 14.37 Billion CNY | -0.84% |
| 2021 Q4 | 14.33 Billion CNY | 6.62% |
| 2021 Q3 | 13.44 Billion CNY | 9.73% |
| 2021 FY | 14.33 Billion CNY | 53.7% |
| 2021 Q1 | 12.02 Billion CNY | 28.95% |
| 2021 Q2 | 12.25 Billion CNY | 1.88% |
| 2020 Q3 | 9.38 Billion CNY | 6.91% |
| 2020 FY | 9.32 Billion CNY | 17.15% |
| 2020 Q1 | 8.39 Billion CNY | 5.43% |
| 2020 Q2 | 8.78 Billion CNY | 4.61% |
| 2020 Q4 | 9.32 Billion CNY | -0.64% |
| 2019 Q4 | 7.96 Billion CNY | -2.52% |
| 2019 FY | 7.96 Billion CNY | 8.25% |
| 2019 Q1 | 7.24 Billion CNY | -1.53% |
| 2019 Q2 | 7.61 Billion CNY | 5.18% |
| 2019 Q3 | 8.16 Billion CNY | 7.22% |
| 2018 FY | 7.35 Billion CNY | 2.93% |
| 2018 Q4 | 7.35 Billion CNY | 5.41% |
| 2018 Q3 | 6.97 Billion CNY | 0.14% |
| 2018 Q2 | 6.96 Billion CNY | -2.92% |
| 2018 Q1 | 7.17 Billion CNY | 0.44% |
| 2017 Q1 | 5.66 Billion CNY | -5.79% |
| 2017 Q4 | 7.14 Billion CNY | 17.25% |
| 2017 Q3 | 6.09 Billion CNY | 8.9% |
| 2017 Q2 | 5.59 Billion CNY | -1.2% |
| 2017 FY | 7.14 Billion CNY | 18.85% |
| 2016 Q3 | 4.77 Billion CNY | 5.93% |
| 2016 FY | 6.01 Billion CNY | 43.64% |
| 2016 Q4 | 6.01 Billion CNY | 25.91% |
| 2016 Q1 | 4.5 Billion CNY | 7.67% |
| 2016 Q2 | 4.5 Billion CNY | 0.03% |
| 2015 Q2 | 3.73 Billion CNY | 17.53% |
| 2015 FY | 4.18 Billion CNY | 42.32% |
| 2015 Q4 | 4.18 Billion CNY | 3.26% |
| 2015 Q3 | 4.05 Billion CNY | 8.57% |
| 2015 Q1 | 3.17 Billion CNY | 8.02% |
| 2014 Q1 | 2.22 Billion CNY | 7.17% |
| 2014 Q2 | 3.04 Billion CNY | 37.07% |
| 2014 Q3 | 2.92 Billion CNY | -4.1% |
| 2014 Q4 | 2.94 Billion CNY | 0.73% |
| 2014 FY | 2.94 Billion CNY | 41.9% |
| 2013 Q1 | - CNY | 0.0% |
| 2013 Q4 | 2.07 Billion CNY | 0.0% |
| 2013 FY | 2.07 Billion CNY | 35.98% |
| 2012 FY | 1.52 Billion CNY | 16.51% |
| 2011 FY | 1.3 Billion CNY | 18.43% |
| 2010 FY | 1.1 Billion CNY | 61.17% |
| 2009 FY | 685.4 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Cachet Pharmaceutical Co., Ltd. | 17.12 Billion CNY | 2.765% |
| ZJAMP Group Co., Ltd. | 20.31 Billion CNY | 18.047% |
| Luyan Pharma Co.,Ltd. | 11.79 Billion CNY | -41.156% |
| Ji Yao Holding Group Co., Ltd. | 1.91 Billion CNY | -769.859% |